We are all excited by this product.It feels great and dries matt on to the skin.
H.A. Intensifier is a multi-beneficial corrective serum proven to amplify skin’s hyaluronic acid levels. This unique formulation contains a high concentration of pure hyaluronic acid, proxylane™, and botanical extracts of licorice root and purple rice to support skin’s hyaluronic acid levels and deliver surface hydration, helping improve the visible appearance of firmness, smoothness, and facial plumpness. This hyaluronic acid serum may be used as part of a home skincare regimen after dermal fillers; always consult with your physician for individual at-home advice.
- Amplifies skin’s hyaluronic acid levels by 30%
- Reduces the look of crow’s feet, nasolabial folds (parenthesis around the mouth or laugh lines), and marionette lines (lines from the corners of the mouth down to chin) for smoother, firmer skin
- Delivers long lasting hydration to visibly improve skin’s texture
- Unique serum-gel texture format creates a smooth canvas on skin
- Paraben- and dye-free, ideal for all skin type
While hyaluronic acid is a powerful hydrator, the size of the hyaluronic acid molecules are too large for optimal skin absorption. H.A. Intensifier uniquely combines surface-hydrating hyaluronic acid with 10% proxylane™ and an optimal concentration of licorice and purple rice extracts to support skin’s hyaluronic acid levels.
In a 12-week clincial study, H.A. Intensifier significantly improved the appearance of key ageing indicators:
- 23% improvement in plumpness
- 9% decrease in sagginess
- 11% improvement in firmness
- 13% improvement in elasticity
- 18% improvement in texture
Protocol: A 12-week, single-center, clinical study was conducted on 59 females, ages 42-60, with mild to moderate facial sagging and loss of firmness, rough skin texture, nasolabial fold wrinkles, marionette lines, and presence of fine lines/wrinkles in the crow’s feet area. H.A. Intensifier was used twice daily in conjunction with SkinCeuticals Gentle Cleanser and a sunscreen. Efficacy and tolerability evaluations were conducted at baseline and at weeks 4, 8, and 12.
See more on the link below.